BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paranjapye A, Ruffin M, Harris A, Corvol H. Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity. J Cyst Fibros 2020;19 Suppl 1:S10-4. [PMID: 31734115 DOI: 10.1016/j.jcf.2019.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hanssens LS, Cellauro S, Duchateau J, Casimir GJ. Immunoglobulin G: A useful outcome marker in the follow-up of cystic fibrosis patients? Immun Inflamm Dis 2021;9:608-14. [PMID: 33783131 DOI: 10.1002/iid3.426] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Callebaut I, Mense M, Farinha CM. Exploring the basic mechanisms in Cystic Fibrosis: Promoting data presentation and discussion at the 16th ECFS Basic Science Conference. J Cyst Fibros 2020;19 Suppl 1:S1-4. [PMID: 31932104 DOI: 10.1016/j.jcf.2019.12.013] [Reference Citation Analysis]
3 Yalçıntepe S, Gürkan H, Atlı E, Sayın NC, Başaran ÜN. Two Cases of Cystic Fibrosis with Compound Heterozygous Variants Reported for the First Time. Balkan Med J 2020;37:297-8. [PMID: 32106665 DOI: 10.4274/balkanmedj.galenos.2020.2019.11.128] [Reference Citation Analysis]
4 Ekinci İB, Hızal M, Emiralioğlu N, Özçelik U, Yalçın E, Doğru D, Kiper N, Dayangaç-Erden D. Differentially expressed genes associated with disease severity in siblings with cystic fibrosis. Pediatr Pulmonol 2021;56:910-20. [PMID: 33369261 DOI: 10.1002/ppul.25237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Cuevas-Ocaña S, Laselva O, Avolio J, Nenna R. The era of CFTR modulators: improvements made and remaining challenges. Breathe (Sheff) 2020;16:200016. [PMID: 33304402 DOI: 10.1183/20734735.0016-2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 de Poel E, Spelier S, Korporaal R, Lai KW, Boj SF, Conrath K, van der Ent CK, Beekman JM. CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy. Front Mol Biosci 2021;8:698358. [PMID: 34604301 DOI: 10.3389/fmolb.2021.698358] [Reference Citation Analysis]
7 Olszowiec-Chlebna M, Mospinek E, Jerzynska J. Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years' experience in Lodz Voivodship. Ital J Pediatr 2021;47:87. [PMID: 33836782 DOI: 10.1186/s13052-021-01040-5] [Reference Citation Analysis]
8 Hall FS, Chen Y, Resendiz-Gutierrez F. The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. Brain Behav Evol 2020;95:230-46. [PMID: 33849024 DOI: 10.1159/000516169] [Reference Citation Analysis]
9 Kiseleva AV, Klimushina MV, Sotnikova EA, Divashuk MG, Ershova AI, Skirko OP, Kurilova OV, Zharikova AA, Khlebus EY, Efimova IA, Pokrovskaya MS, Slominsky PA, Shalnova SA, Meshkov AN, Drapkina OM. A Data-Driven Approach to Carrier Screening for Common Recessive Diseases. J Pers Med 2020;10:E140. [PMID: 32971794 DOI: 10.3390/jpm10030140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]